4 Results for "

PC3-pip

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PC3-pip" in MCE Product Catalog:

Cat. No.: HY-172366
CAS No.: 3055338-52-5
Target:  

PSMA

Research Areas:  

Cancer

BQ0413 exhibits good affinity to PSMA with a KD of 89 pM. BQ0413 exhibits good uptake and internalization property with an internalization rate of 44% in PC3-pip cell. BQ0413 can be used as tumor imaging agent when labeled with 99mTc .
loading...
    loading...
Cat. No.: HY-163683
CAS No.: 2375590-67-1
Research Areas:  

Cancer

EB-PSMA-617 is a modified form of PSMA-617 that has enhanced pharmacokinetic properties by conjugating it to Evans Blue (EB) to extend its circulation half-life to improve prostate tumor uptake and radiotherapy efficacy. In preclinical studies using PC3-PIP-loaded mice, EB-PSMA-617 demonstrated prolonged blood half-life, increased accumulation in PSMA-positive tumors, and successful tumor elimination with lower radioactivity .
loading...
    loading...
Cat. No.: HY-181830
Target:  

PD-1/PD-L1 PSMA LYTACs

Research Areas:  

Cancer

Atz-L5 is a PD-L1 PTAC (PSMA-targeted chimera) degrader (DC50: 18 pM in PC3-PIP cells; 2 pM in LNCaP cells) and LYTAC. Atz-L5 promotes lysosomal degradation of PD-L1 in PSMA-positive prostate cancer cells. Atz-L5 is applicable to the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-182240
Target:  

PSMA

Research Areas:  

Cancer

Cy5-ZW2-617 is a PSMA ligand with a IC50 of 4.39 nM. Cy5-ZW2-617 specifically binds to PSMA and is thereby internalized by PSMA-positive cells. Cy5-ZW2-617 shows uptake in PSMA-positive tumor cells and tumor xenografts in mice. Cy5-ZW2-617 can be used for the research of prostate cancer .
loading...
    loading...